-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, QI8Gbz5+GUELM5oLqiEYsAO81fKvHaiBqZLJxs1JE1qoS35m6dLgQZ4V0l3g2W+h M5H9aHZZZuTzUXiKi1ezoA== 0001181431-08-037007.txt : 20080605 0001181431-08-037007.hdr.sgml : 20080605 20080605140418 ACCESSION NUMBER: 0001181431-08-037007 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20080604 FILED AS OF DATE: 20080605 DATE AS OF CHANGE: 20080605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: MAP Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001401923 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 200507047 STATE OF INCORPORATION: DE BUSINESS ADDRESS: STREET 1: 2400 BAYSHORE PARKWAY, SUITE 200 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 BUSINESS PHONE: 650-386-3100 MAIL ADDRESS: STREET 1: 2400 BAYSHORE PARKWAY, SUITE 200 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GIANAKAKOS ANASTASIOS CENTRAL INDEX KEY: 0001413822 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33719 FILM NUMBER: 08882629 BUSINESS ADDRESS: BUSINESS PHONE: (650) 386-3100 MAIL ADDRESS: STREET 1: 2400 BAYSHORE PARKWAY STREET 2: SUITE 200 CITY: MOUNTAIN VIEW STATE: CA ZIP: 94043 4 1 rrd209897.xml FORM 4 X0202 4 2008-06-04 0 0001401923 MAP Pharmaceuticals, Inc. MAPP 0001413822 GIANAKAKOS ANASTASIOS C/O MAP PHARMACEUTICALS, INC. 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043 0 1 0 0 SVP, COR & Business Dev Common Stock 2008-06-04 4 M 0 3500 0.7434 A 3500 D Common Stock 2008-06-04 4 S 0 100 11.81 D 3400 D Common Stock 2008-06-04 4 S 0 300 12.12 D 3100 D Common Stock 2008-06-04 4 S 0 300 12.43 D 2800 D Common Stock 2008-06-04 4 S 0 30 12.64 D 2770 D Common Stock 2008-06-04 4 S 0 370 12.71 D 2400 D Common Stock 2008-06-04 4 S 0 300 13.25 D 2100 D Common Stock 2008-06-04 4 S 0 300 13.13 D 1800 D Common Stock 2008-06-04 4 S 0 158 13.06 D 1642 D Common Stock 2008-06-04 4 S 0 42 12.99 D 1600 D Common Stock 2008-06-04 4 S 0 100 13.00 D 1500 D Common Stock 2008-06-04 4 S 0 42 13.11 D 1458 D Common Stock 2008-06-04 4 S 0 100 12.86 D 1358 D Common Stock 2008-06-04 4 S 0 500 12.55 D 858 D Common Stock 2008-06-04 4 S 0 300 12.76 D 558 D Common Stock 2008-06-04 4 S 0 558 12.50 D 0 D Stock Option (Right to Buy) 0.7434 2008-06-04 4 M 0 3500 0 D 2016-10-16 Common Stock 3500 114143 D The sale of the reported shares is made pursuant to terms of 10b5-1 plan in effect at the time of sale of the shares. The option is exercisable as it vests: 25% of the total number of option shares vests and becomes exercisable on the first anniversary of the vesting commencement date. Thereafter, 1/48th of the total number of option shares becomes exercisable cumulatively on each monthly anniversary for 36 months so that the entire number of option shares becomes fully vested. /s/ Anastasios Gianakakos 2008-06-05 -----END PRIVACY-ENHANCED MESSAGE-----